Anti-Luteinizing Hormone / Choriogonadotropin Receptor (LHCGR) Monoclonal Antibody(Clone: LHCGR/1415), Clone: [LHCGR/1415], Mouse

Artikelnummer: ABI-36-2702
Artikelname: Anti-Luteinizing Hormone / Choriogonadotropin Receptor (LHCGR) Monoclonal Antibody(Clone: LHCGR/1415), Clone: [LHCGR/1415], Mouse
Artikelnummer: ABI-36-2702
Hersteller Artikelnummer: 36-2702
Alternativnummer: ABI-36-2702-100UG
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: FACS, IF
Spezies Reaktivität: Human
Immunogen: Recombinant fragment (around aa 70-410) of human LHCGR protein (exact sequence is proprietary)
Alternative Synonym: Gonadotropin receptor, GTHR-II, HHG, LCGR, LGR2, LH-R, LH/CG-R, LH/CGR, LHCGR, LHR, LHRHR, LSH-R, Luteinizing hormone receptor, Luteinizing hormone/choriogonadotropin receptor, Lutropin choriogonadotropic receptor, Lutropin-choriogonadotropic hormone receptor, ULG5
Recognizes a protein of 78-85kDa, which is identified as Luteinizing hormone / choriogonadotropin receptor. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone / choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women.
Klonalität: Monoclonal
Klon-Bezeichnung: [LHCGR/1415]
NCBI: 3973
UniProt: P22888
Application Verdünnung: Flow Cytometry (1-2ug/million cells), Immunofluorescence (1-2ug/ml),